People, Product and Agency News from the Jan. 7th MM&M News Brief

Share this article:

People News
MANUFACTURERS

Schering-Plough promoted Ted Lithgow to group vice president,commercial development and GailThornton vice president, global communications,Europe, Canada, MiddleEast, Africa, Japan, LatinAmerica and Far East regions.

SUPPLIERS
Alliance Healthcare Information named Kevin Hunter as manager of business development.

Solucient named Cynthia Kujawa as vice president,human resources.

AGENCIES
Dorland Global Health Communications has appointed Joe Soto to
lead its West Coast business as general manager of the San Francisco office. Soto joined the Philadelphia-based firm a year ago from FCB Healthcare, where he was general
manager of that firm's San Francisco office. He reports to Rita Sweeney, president and chief operating officer of Dorland.

TMP Worldwide Advertising & Communications named Greta Sherman senior vice president of strategic planning, healthcare.

Palio Communications named Analia Del Giorgio as senior graphic designer and Bruce Weinberg as senior copywriter. Del Giorgio was a freelance graphic designer for several academic and corporate clients.Weinberg was owner and creative director at @WAO Creative. Media news

Media News

The MD Net Guide series of peer reviewed journals is adding MD Net Guide: Focus on Geriatric Medicine, as a supplement to its portfolio of publications. The new title will
debut in the first quarter of 2005.

The Society of Hospital Medicine has named John Wiley & Sons to
publish the Society's newsletter, TheHospitalist, previously published inhouse. The Society also hired Pharmaceutical Media Inc. to handle
advertising sales support for the title that goes to 12,000 hospital-based physicians.

Company news

Bristol-Myers Squibb and Ventiv Pharma Services have signed a multiyear
service agreement under which Ventiv will provide a sales force of more than 375 representatives focusing on Cefzil and Tequin. Meanwhile, BMS is reportedly in talks with several suitors to sell its Excedrin line of pain relievers and other OTC products
for as much as $1 billion.

Adolor has signed a two-year agreement to co-promote Glaxo-SmithKline's anti-thrombotic agent Arixtra in the U.S.

Account wins

GSW Worldwide was named agency of record by The Valley Hospital,
a 451-bed acute-care hospital in Ridgewood, N.J. The account will be
based in GSW Worldwide's New York office. The Vigilante Advertising Agency,
a unit of Publicis, was named by NitroMed as the advertising agency for BiDil, a new drug that reduces deaths among African Americans from advanced heart failure. Vigilante will handle creative for print and broadcast.

Griff/SMC completed an integrated marketing communications campaign for the radiation oncology division of Philips Medical.

Palio Communications was selected by Cephalon as the professional agency of record for record for OraVescent fentanyl.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...